Results

Total Results: 1,170 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

241. Comparative Effectiveness of Treatment for Phenylketonuria | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/phenylketonuria/research-protocol
     February 08, 2011 - dopamine, in the brain. 16,17 Despite potential benefits, there is uncertainty about the efficacy and safety … of the long-term use of LNAAs and about the target patient population, including the appropriateness … , the safety and efficacy of using sapropterin dihydrochloride in children under the age of 8, including … long-term effects of pharmacological treatment or the desired Phe concentration ranges for various patient … Primary outcomes in a patient: Decreasing Phe levels in the blood Improved nutritional status Quality

242. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
     October 01, 2014 - DBS to the subcallosal cingulate white matter supported the long-term safety and antidepressant efficacy … The safety of ECT in patients with an implanted DBS system has not been established. … ketamine would have a minimal impact on health outcomes in the absence of data on long-term effects, safety … Efficacy and safety of mifepristone for the treatment of psychotic depression. … Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects

243. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotics-children/research-protocol
     June 04, 2010 - , patient insight into illness. … insight into illness Patient or parent/care provider reported outcomes, including levels of physical … insight into illness Patient or parent/care provider reported outcomes, including levels of physical … followup), patient baseline characteristics (diagnosis and age at diagnosis, age, sex, race, weight, … Adults Pediatric use: safety & effectiveness not established in patients <18 yr 1. agranulocytosis

244. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
     December 04, 2015 - Within each KQ, we will assess outcomes for subgroups of patients or studies based on patient and clinical … (patientsafety, effectiveness, and policy challenges. … Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and … Drug Safety. 2011 Aug 1;34(8):651-68. PMID: 21751826. 17.

245. Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
     May 19, 2010 - Comparative Effectiveness of Off-label Use of Atypical Antipsychotics reviewed the scientific evidence on the safety … risk of death and antipsychotics drugs, and comparison of the development of adverse effects between patients … Studies that did not report any outcomes of efficacy, effectiveness, safety/adverse events, or utilization … We will define loss to follow-up as the number of patients excluded from efficacy analyses, expressed … as a proportion of the number of patients randomized.

246. Health Occupations | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/health-occupations
     January 17, 2012 - Presentation) Presentation April 19, 2012 Using Deliberative Methods to Engage Patients … White Paper September 30, 2009 Instrumental Variable Methods in Comparative Safety … Effectiveness Systematic Reviews Methods Guide – Chapter October 5, 2009 How Patients … Meta-Analysis for Binary Outcomes Research Report March 20, 2013 Eliciting Patients … February 23, 2012 Clinical Effectiveness of Coronary Stents in the Elderly: Results From 262,700 Patients

247. Disposition of Comments Report for CER 203 ADHD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
     January 01, 2018 - In my assessment, post-marketing surveillance studies of effectiveness and safety are badly missing … These outcomes were seen as being both patient-centered and most critical for decisionmaking across … Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention- … A long-term o pen-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents … Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized

248. Ace-Inhibitor-Arb-Update-Surveillance-160328 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
     March 28, 2016 - $Comparative$efficacy$and$safety$of$aliskiren$and$ irbesartan$in$patients$with$hypertension$and$metabolic … $Antihypertensive$efficacy$and$ safety$of$olmesartan$medoxomil$and$ramipril$in$elderly$patients$with … $ rather$than$hypertensive$ patients),$it$highlights$the$safety$ concerns$associated$with$ combining … $Antihypertensive$efficacy$and$safety$of$olmesartan$medoxomil$and$ ramipril$in$elderly$patients$with … $Comparative$efficacy$and$safety$of$aliskiren$and$irbesartan$in$patients$with$ hypertension$and$metabolic

249. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - daily, which is achieved by doubling the dose at approximately 2-week intervals, as tolerated by the patient … For Results Key Question 2, safety information, please note that ACE inhibitors pose unique, albeit … congestive heart failure, or nephropathy); however all have examined an overlapping set of efficacy and safety … of “class effects”, specifically related to ACEIs and ARBs, discussing that mechanism of action, safety … We underscore the importance of updating any corollary materials (e.g., patient guides) in order to

250. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … Effectiveness and Safety of Drug- Eluting Stents in Ontario. … Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary … Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. … Unadjusted baseline characteristics of patients in study population Patient Characteristics Study

251. Draft Technical Brief - Healthcare Systems Level Strategies to Address Racial and Ethnic Disparities in Health and Healthcare: An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-system-draft-technical-brief.pdf
     February 01, 2023 - Patient-level interventions refer to those targeted at patients, such as patient education. … an Urban Safety-Net Setting. … Community–Clinical Linkages: The Effects of the Healthy Here Wellness Referral Center on Chronic Disease Indicators … Impact of a Primary Care CKD Registry in a US Public Safety-Net Health Care Delivery System: A Pragmatic … Evaluating Patient Navigation to Improve First Appointment No-show Rates in Uninsured Patients with

252. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - As a clinician, I want to know how best to treat an individual patient with a defined subtype of JIA … One patient experiences a hematoma occurring on day 108 which was deemed unrelated to the study drug … Acute infusional adverse events were reported in one (2%) patient in the abatacept group and two (3% … All studies of safety were addressed in KQ3. … Of the 14 patients enrolled in the infliximab arm, 5 patients failed to complete 12 months – 4 because

253. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
     September 01, 2008 - However, the addition of insulin to treatment Comparative Effectiveness, Safety, and Indications of … A number of patient-related factors have been identified that may help physicians to select patients … Insulin lispro 75/25 was associated with a higher rate of overall hypoglycemia measured as episode/patient … Key Question 4: Effect of premixed insulin analogues based on patient characteristics Comparison of … injection patterns and glucose testing depending on the type of medication regimen prescribed, evaluating patient

254. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rural-telehealth/protocol
     January 15, 2021 - or patient populations.  … Population(s): Rural individual patients, patient families/care partners, and patient populations … including but not limited to time to diagnosis or time to treatment KQ2: Indicators and measures … KQ2: Indicators and measures of uptake of telehealth (e.g., rates of use, timing to implementation) … The Rural Health Safety Net Under Pressure: Rural Hospital Vulnerability . 2020.

255. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
     August 23, 2010 - What are the potential safety issues and harms associated with the use of non-invasive diagnostic techniques … Guiding question 3: What published and unpublished studies have reported on the use and safety of these … Provide a synthesis of the following information: i Indication/patient inclusion criteria ii Type … of techniques/modalities iii Study design and size iv Role of the test in patient management v … Strategies for early melanoma detection: Approaches to the patient with nevi.

256. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - significantly increased the regulatory bar for gaining approval—specifically regarding preapproval safety … data and postmarket safety evaluation—set forth by the U.S. … Kushner and colleagues announced results from a phase III clinical trial (SEQUEL) evaluating the safety … However, potential increase in per- patient costs might serve as barriers to acceptance by some patients … Safety and efficacy study of EndoBarrier in subjects with type II diabetes and obesity.

257. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
     January 01, 2013 - Cohort design has the potential to increase efficiency Well suited for rare adverse events in vaccine safety … The design was originally proposed for rare adverse events in vaccine safety studies for which it seems … Regardless of the design chosen, selection of appropriate data source(s), the patient population, inclusion … Regardless of the design chosen, selection of appropriate data source(s), the patient population, inclusion … Regardless of the design chosen, selection of appropriate data source(s), the patient population, inclusion

258. First and Second Generation Antipsychotics for Children and Young Adults-Comparative Effectiveness Review Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotics-children-update/research-protocol
     December 07, 2015 - Within each KQ, we will assess outcomes for subgroups of patients or studies based on patient and clinical … Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. … Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and … Drug Safety. 2011 Aug 1;34(8):651-68. PMID: 21751826. Correll CU, Penzner JB, Parikh UH, et al. … Limited evidence in children <12 years Use and safety have not been evaluated in other childhood

259. Emerging MRI Technologies for Imaging Musculoskeletal Disorders under Loading Stress (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-disorders-imaging_disposition-comments.pdf
     November 01, 2011 - Safety: The ramfiicaitons regarding potential need for alternative imaging methods (pg 16, lines 10- … 13) to rule out specific pathologies is to some extent a safety issue (e.g. ? … safety/outcomes. … vs. an adverse event related to the safety of the device or procedure? … frequency of positive MRI exams on clinically asymptomatic patients.

260. Urinary-Incontinence-Treatment Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
     October 29, 2012 - • There are no safety concerns Summary Decision: This CER’s priority for updating is Low … UUI in 40% patients on 150 U; p=0.022 • >75% improvement versus baseline in UUI in 40% patients on 100 … UUI in 40% patients on 150 U; p=0.022 >75% improvement versus baseline in UUI in 40% patients on … The  efficacy  and  safety  of  solifenacin   in  patients  with  overactive  bladder … in 40% patients on 150 U; p=0.022 >75% improvement versus baseline in UUI in 40% patients on 100